Novel ‘GaEl antigenic patches’ identified by ‘reverse epitomics’ approach to design multi-patch vaccines against NIPAH infection, a silent threat to global human health

Author:

Srivastava SukritORCID,Kolbe MichaelORCID

Abstract

AbstractBackgroundNipah virus (NiV) is a zoonotic virus that causes lethal encephalitis and respiratory disease with the symptom of endothelial cell-cell fusion. Several NiV outbreaks have been reported since 1999 with nearly annual occurrences in Bangladesh. The outbreaks had high mortality rates ranging from 40 to 90%. No specific vaccine has yet been reported against NiV.MethodologyRecently, several vaccine candidates and different designs of vaccines composed of epitopes against NiV were proposed. Most of the vaccines target single protein or protein complex subunits of the pathogen. The Multi-epitope vaccines proposed also cover a largely limited number of epitopes and hence their efficiency is still pending. To address the urgent need for a specific and effective vaccine against NiV infection in the present study, we have utilized the ‘Reverse Epitomics’ approach (“overlapping-epitope-clusters-to-patches” method) to identify ‘antigenic patches’ (Ag-Patches) and utilize them as immunogenic composition for Multi-Patch vaccine (MPV) design. The designed MPVs were analyzed for immunologically crucial parameters, physiochemical properties and interaction with Toll-like receptor 3 ectodomain.ResultsIn total 30 CTL (Cytotoxic T lymphocyte) and 27 HTL (Helper T lymphocytes) antigenic patches were identified from the entire NiV proteome based on the clusters of overlapping epitopes. These identified Ag-Patches cover a total of discreet 362 CTL and 414 HTL epitopes from entire proteome of NiV. The antigenic patches were utilized as immunogenic composition for the design of two CTL and two HTL multi-patch vaccines. The 57 antigenic patches utilized here cover 776 overlapping epitopes targeting 52 different HLA class I and II alleles providing a global ethnically distributed human population coverage of 99.71%. Such large number of epitope coverage resulting in large human population coverage cannot be reached with single protein/subunit or multi-epitope based vaccines. The reported antigenic patches also provide potential immunogenic composition for early detection diagnostic kits for NiV infection. Further, all the MPVs & Toll-Like Receptor ectodomain complexes show stable nature of molecular interaction with numerous hydrogen bonds, salt bridges and non-bounded contacts formation and acceptable root mean square deviation and fluctuation. The cDNA analysis show a favorable large scale expression of the MPV constructs in human cell line.ConclusionBy utilizing the novel ‘Reverse epitomics’ approach highly immunogenic novel ‘GaEl antigenic patches’ (GaEl Ag-Patches) a synonym term for ‘antigenic patches’, were identified and utilized as immunogenic composition to design four MPVs against NiV. We conclude that the novel Multi-Patch Vaccines is a potential candidate to combat NiV, with greater effectiveness, high specificity and large human population coverage worldwide.

Publisher

Cold Spring Harbor Laboratory

Reference94 articles.

1. Molecular epidemiology and phylogeny of nipah virus infection: a mini review;Asian Pacific journal of tropical medicine,2016

2. Paramyxovirus glycoproteins and the membrane fusion process;Current clinical microbiology reports,2016

3. Ang, B.S. , Lim, T.C. and Wang, L ., 2018. Nipah Virus Infection. Journal of clinical microbiology, pp.JCM-01875.

4. WHO Report, Surveillance and outbreak alert, Nipah virus; https://www.who.int/health-topics/nipah-virus-infection#tab=tab_1

5. Prioritizing surveillance of Nipah virus in India

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3